A March 16 article, “Study shows low awareness of emergency contraception,” written by Michelle Andrews of Kaiser Health News reported the conclusions of a study published in the March issue of the Journal of Adolescent Health.
Her article repeated the report’s assertion that 42 percent of 93 sexually active males, ages 13 to 24, interviewed for the study were aware of the existence of emergency contraception such as Plan B One-Step. Dr. Paritosh Kaul, co-author of the report and associate professor of pediatrics at the University of Colorado School of Medicine, stated, “The boys are listening, and health care providers need to talk to the boys.”
Health care providers need to talk with their sexually active patients about all the effects of the use of chemical compounds such as the synthetic hormone levonorgestrel found in the Plan B One-Step pill and in the Mirena IUD.
In addition to treating the natural healthy bodily human functions of intercourse and conception and pregnancy as disease conditions, these (and other) chemical preparations can cause an abortion of the fertilized human embryo/blastocyst by inhibiting its implantation on/in the uterine wall, and can increase a woman’s chance of developing breast cancer.
Two peer-reviewed medical meta-studies disclosing these deleterious effects are “The breast cancer epidemic: 10 facts,” Linacre Quarterly, Volume 81, Issue 3, 2014, and “Appreciation for the analysis of how levonorgestrel works and reservation with the use of meloxicam as emergency contraceptives,” Linacre Quarterly, Volume 83, Issue 1, 2016. The lead author of both of these articles is A. Patrick Schneider, M.D. (University of Kentucky), M.P.H. (Harvard University).
I served as one of the proofreaders for both of these articles.
Otto R. Piechowski